Newsroom University of Manchester (respiratory)
Filter by year
2022
03
March
2022
|
23:33
Europe/London
The world’s first phase three trials of a new drug have shown that it can ease the often distressing symptom of chronic cough with few side effects.
Read more
2021
15
December
2021
|
09:54
Europe/London
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections. TaBriX’s initial focus is on the treatment of drug-resistant TB.
Read more
29
November
2021
|
16:00
Europe/London
Levels of a fungus hazardous to patients with respiratory disease are more abundant in rooms with outside facing windows during the summer months, University of Manchester and Manchester University NHS Foundation Trust (MFT) researchers have …
Read more
26
August
2021
|
09:28
Europe/London
A 70-year-old woman, forced to live with cough since her 40s, is ‘excited’ to be the first person in the world to receive a potential new cough treatment at the NIHR Manchester Clinical Research Facility (CRF).
Read more
2020
20
May
2020
|
14:56
Europe/London
A University of Manchester study has linked being overweight with an increased risk of getting COVID-19 in patients with one the UK’s most common lung diseases.
Read more
26
February
2020
|
00:00
Europe/London
Two trials of a new drug have shown that at low doses, it can ease the often distressing symptoms of chronic cough with minimal side effects.
Read more
08
January
2020
|
16:08
Europe/London
Aaron Amat/Shutterstock
By David Ray, University of Oxford and Gareth Kitchen, University of Manchester
All life on Earth has evolved to cope with a rotating planet which results in the predictable transition between day and night. …
Read more
2019
27
March
2019
|
15:45
Europe/London
Patients with some of the most common lung diseases are substantially more likely to suffer a heart attack and develop other major heart problems according to new research.
Read more
19
March
2019
|
15:00
Europe/London
Around 1 in 15 people affected by tuberculosis are likely get the treatable fungal infection aspergillosis according to new research by experts at The University of Manchester and Gulu Referral Hospital, Uganda.
Read more
2018
29
October
2018
|
15:00
Europe/London
A systematic review of research has revealed that the toxic effects on the lung of drugs commonly taken to treat a range of common conditions is much more widespread than thought.
Read more
